East Calder, United Kingdom

Michael J Dey

USPTO Granted Patents = 6 


Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 171(Granted Patents)


Location History:

  • West Lothian, GB (1990 - 1991)
  • East Calder, GB (1990 - 1993)

Company Filing History:


Years Active: 1990-1993

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Michael J Dey

Introduction

Michael J Dey is a notable inventor based in East Calder, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of long-acting formulations for calcium channel blockers. With a total of 6 patents to his name, Dey's work has had a considerable impact on medication delivery systems.

Latest Patents

Among his latest patents is the "Long acting calcium channel blocker composition." This invention discloses an improved long-acting sustained release pharmaceutical composition for dihydropyridine calcium channel blockers. The composition features a pH-dependent binder and is designed to provide slow, sustained release of a therapeutically effective amount of the calcium channel blocker over a period of at least 24 hours. This innovation allows for once-daily administration, enhancing patient compliance. Another significant patent is the "Long acting nicardipine hydrochloride formulation," which similarly focuses on sustained release pharmaceutical compositions for dihydropyridine calcium channel blockers.

Career Highlights

Throughout his career, Michael J Dey has worked with prominent companies such as Syntex (U.S.A.) Inc. and Syntex Pharmaceuticals, Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovations.

Collaborations

Dey has collaborated with notable coworkers, including Alastair B Selkirk and Calum B MacFarlane. Their combined efforts have likely fostered advancements in the pharmaceutical field.

Conclusion

Michael J Dey's contributions to pharmaceutical innovations, particularly in the area of long-acting calcium channel blockers, demonstrate his commitment to improving medication delivery systems. His patents reflect a dedication to enhancing patient care through effective pharmaceutical compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…